Nima Farzan is a director of Keros Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Kinnate Biopharma Inc.
5 Apr 24
4
Keros Therapeutics, Inc.
8 Jun 23
4/A
Kinnate Biopharma Inc.
15 Feb 23
4
Kinnate Biopharma Inc.
14 Feb 23
4
Keros Therapeutics, Inc.
3 Jun 22
4
Kinnate Biopharma Inc.
15 Feb 22
4
Keros Therapeutics, Inc.
3 Jun 21
4
Kinnate Biopharma Inc.
16 Feb 21
3
Kinnate Biopharma Inc.
2 Dec 20
4
Keros Therapeutics, Inc.
29 May 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Apr 24 | KNTE Kinnate Biopharma | Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,186 | 0.00 | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.78 | 750,000 | 5.09 mm | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 10.03 | 400,000 | 4.01 mm | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 35.38 | 275,000 | 9.73 mm | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.63 | 437,413 | 2.46 mm | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.57 | 1,281,642 | 3.29 mm | 0 |
6 Jun 23 | KROS Keros Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 48.79 | 10,000 | 487.90 k | 10,000 |
10 Feb 23 | KNTE Kinnate Biopharma | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 6.78 | 750,000 | 5.09 mm | 215,000 |
10 Feb 23 | KNTE Kinnate Biopharma | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 6.78 | 750,000 | 5.09 mm | 750,000 |